QIAGEN

QIAGEN announced the launch of EZ2 Connect MDx for use in diagnostic laboratories, making the IVD platform for automated sample processing available…

Fueled by increased demand from pharmaceutical companies and a $16.5 million new funding in 2022 to accelerate innovative cancer trial enrollment…

ATCC’s collection of high-fidelity authenticated DNA-seq and RNA-seq datasets to be included in QIAGEN’s databases for biotechnology and…

Expanding range of applications for growing base of QIAcuity digital PCR instruments Two new collaborations: Atila BioSystems expands menu to…

Cloud application marks another milestone for QIAGEN by adding guidance for customers along the entire product portfolio Application covers…

Enabling Labs to Efficiently Process Increasingly Complex Samples with over 3,000 Proven Protocols, Advanced Digital Capabilities and Connectivity…